#疫苗

Europe Authorizes Moderna mRNA Combo Vaccine First: A Divergence in Global Vaccine Strategy

Moderna's combined mRNA vaccine has been authorized in Europe, revealing a divergence in global vaccine strategy. Europe's proactive approach contrasts with the U.S., where political pressure has stalled application progress, forcing pharmaceutical firms to adopt flexible global strategies.

Williams·Apr 26, 2026